Skip to main content
Beni-Suef University Journal of Basic and Applied Sciences
Download PDF

Correction: Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial

Beni-Suef University Journal of Basic and Applied Sciences volume 13, Article number: 32 (2024) Cite this article

The Original Article was published on 08 November 2023

Correction: Beni-Suef Univ J Basic Appl Sci (2023) 12:104 https://doi.org/10.1186/s43088-023-00442-0

The authors would like to inform the readership that this article, published in November 2023, presents the first part of our research on the use of DPP-4 and SGLT-2 inhibitors in Egyptian diabetic patients. Part two of this research, which studies the prolonged impact of the medications discussed in this paper, can be found in [1].

Reference

  1. Zakaraia HG, Salem HF, Mostafa MAA, Ali AM, Rabea H (2023) Adding empagliflozin to sitagliptin plus metformin vs. adding sitagliptin to empagliflozin plus metformin as triple therapy in Egyptian patients with type 2 diabetes: a 12-week open trial. Eur Rev Med Pharmacol Sci. https://doi.org/10.26355/eurrev_202308_33300

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Pharmacy Department, Faculty of Pharmacy, University of Sadat City, P.O. Box 32897, Sadat City, Menoufia, Egypt

    Haitham G. Zakaraia

  2. Pharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, P.O. Box 62514, Beni-Suef, Egypt

    Heba F. Salem

  3. Internal Medicine Department, Faculty of Medicine, October 6 University, P.O. Box 12585, Giza, Egypt

    Mostafa A. A. Mostafa

  4. Clinical Pharmacy Department, Faculty of Pharmacy, October 6 University, P.O. Box 12585, Giza, Egypt

    Ahmed M. Ali

  5. Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, P.O. Box 62514, Beni-Suef, Egypt

    Hoda M. Rabea

Authors
  1. Haitham G. Zakaraia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heba F. Salem
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mostafa A. A. Mostafa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmed M. Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hoda M. Rabea
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haitham G. Zakaraia.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zakaraia, H.G., Salem, H.F., Mostafa, M.A.A. et al. Correction: Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial. Beni-Suef Univ J Basic Appl Sci 13, 32 (2024). https://doi.org/10.1186/s43088-024-00487-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s43088-024-00487-9